解读质母细胞瘤的发病性:从线粒细胞衰变失调和SNX7作为治疗点的洞察力

Yuanlong Zhang1, Binghong Chen1, Renfu Liu2

  • 1Department of Neurosurgery, Neurosurgery Research Institute, The First Affiliated Hospital of Fujian Medical University, Fujian, Fuzhou 350005, China; Department of Neurosurgery, Binhai Branch of National Regional Medical Center, The First Affiliated Hospital of Fujian Medical University, Fujian, Fuzhou 350005, China; Fujian Provincial Institutes of Brain Disorders and Brain Sciences, First Affiliated Hospital of Fujian Medical University, Fujian, Fuzhou 350005, China.

Brain research bulletin
|December 30, 2024
PubMed
概括

这项研究表明,排序nexin 7 (SNX7) 通过抑制线粒细胞吸收,驱动质母细胞瘤的进展. 准SNX7为这种侵袭性脑瘤提供了潜在的新疗法策略.

相关概念视频